Avantor (AVTR) Financial Analysis & Valuation | Quarter Chart
Avantor (AVTR)
AVTRPrice: $10.03
Fair Value: 🔒
🔒score
Avantor, Inc. provides products and services to customers in biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and... more
Avantor, Inc. provides products and services to customers in biopharma, healthcare, education and go... more
Description
Shares
| Market Cap | $6.85B | Exchange | NYSE |
| Sector | Healthcare | Industry | Medical - Instruments & Supplies |
| Country | US | CEO | Emmanuel Ligner |
| IPO Date | 2019-05-17 | CAGR | 0.26% |
| Employees | 13,500 | Website | www.avantorsciences.com |
| Div. Yield | — | Payout Ratio | — |
| Buy Back Yield | 0.94% | Total Yield | 0.94% |
AVTR chart loading...
Fundamentals
Technicals
| Enterprise Value | $6.40B | P/E Ratio | 11.8 |
| Forward P/E | 11.79 | PEG Ratio | — |
| P/S Ratio | 1.29 | P/B Ratio | 1.51 |
| P/CF Ratio | 14.71 | P/FCF Ratio | 19.37 |
| EPS | $0.85 | EPS Growth 1Y | — |
| EPS Growth 3Y | — | EPS Growth 5Y | — |
| Revenue Growth 1Y | -1.99% | Gross Margin | 0.32% |
| Operating Margin | -0.04% | Profit Margin | -0.08% |
| ROE | -0.1% | ROA | -0.05% |
| ROCE | -0.03% | Current Ratio | 1.76 |
| Quick Ratio | 1.17 | Cash Ratio | 0.2 |
| Debt/Equity | 0.01 | Interest Coverage | -1.52 |
| Altman Z Score | 1.27 | Piotroski Score | 6 |